- Dose&Care®, a state-of-the-art digital solution to monitor patients' exposure to radiation
- Contrast&Care®, a next-level contrast media injection data management solution enabling imaging centers to collect, archive, examine and share data directly with Guerbet's injectors to help radiologists with patient care
Ad Statistics
Times Displayed: 25472
Times Visited: 569 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
- IBM Watson Patient Synopsis, a radiologist-trained artificial intelligence tool that extracts relevant patient information and summarizes into a tailored and specific dashboard to help physicians make informed diagnostic decisions
About Guerbet
Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019. For more information about Guerbet, please visit www.guerbet.com.
Back to HCB News
